We bought into Illumina (ILMN) on the 3rd of August this year as part of our Stocks in Focus The Trading Portfolio, and it’s a good time to have an update on this position today.
Here’s a quick background information on Illumina.
The company develops and sells cutting-edge technologies used in disease research, drug development, and molecular tests…
